Shots:

• RWE data from CIRN with support from the Public Health Agency of Canada and the Canadian Institutes of Health Research demonstrated that one dose of Vaxzevria was 82% effective against hospitalization or death caused by the Beta/Gamma variants of the SARS-CoV-2 virus
• The vaccine also demonstrated effectiveness against the Delta and Alpha variants with an 87% and 90% reduction of hospitalizations or deaths respectively
• The RWE study includes 69-533 individuals who tested positive for SARS-CoV-2 during Dec’2020 to May’2021 in Canada with 28-705 (6.8%) positive for non-variants of concern SARS-CoV-2 and 40-828 (9.7%) positive for a variant of concern

  | Ref: AstraZeneca | Image: AstraZeneca